Berry Stephen A, Gebo Kelly A, Rutstein Richard M, Althoff Keri N, Korthuis P Todd, Gaur Aditya H, Spector Stephen A, Warford Robert, Yehia Baligh R, Agwu Allison L
From the Departments of *Medicine and †Pediatrics, Johns Hopkins School of Medicine, Baltimore, MD; ‡Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA; §Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; ¶Department of Medicine, Oregon Health and Science University, Portland, OR; ‖Department of Pediatrics, St Jude's Children's Hospital, Memphis, TN; **Department of Pediatrics, University of California, San Diego, CA; ††Department of Medicine, St. Lukes-Roosevelt Hospital Center, New York, NY; and ‡‡Department of Medicine, University of Pennsylvania, Philadelphia, PA.
Pediatr Infect Dis J. 2014 May;33(5):488-94. doi: 10.1097/INF.0000000000000126.
Contemporary trends in hospitalization patterns among perinatally HIV-infected (PHIV) patients are unknown. We describe rates and reasons for hospitalizations stratified by age group during 2003-2010 within a large cohort of PHIV patients.
579 PHIV patients engaged in care at 6 geographically diverse pediatric HIV centers affiliated through the HIV Research Network were included. Modified Clinical Classification Software assigned primary ICD-9 codes into diagnostic categories. Analysis was performed using negative binomial regression with generalized estimating equations.
There were 699 all-cause hospitalizations. The overall rate for the full cohort was 19.9/100 person-years, and overall rates for 0-4, 5-16 and 17-24 year-olds were 25.1, 14.7 and 34.2/100 person-years, respectively. Declines were seen in unadjusted all-cause rates for the whole group [incidence rate ratio per year, 0.93 (0.87-0.99)] and for 5-16 [0.87 (0.76-0.99)] and 17-24 year-olds [0.87 (0.80-0.95)]. After adjustment for CD4, HIV-1 RNA and demographics, rates were no longer declining. Non-AIDS-defining infections and AIDS-defining illnesses together caused 349 (50%) admissions. Declines in these categories drove the overall declines in unadjusted rates. No increases over time were seen for cardiovascular, renal or any other diagnostic categories.
While the declines in hospitalizations are reassuring, continued efforts are needed to address the persistently high infectious and non-infectious morbidity among PHIV patients. Innovative strategies may be most critical for 17-24 year-olds. Lack of increases in cardiovascular and renal admissions provides modest, preliminary reassurance against severe non-infectious complications from longstanding HIV infection and antiretroviral exposure.
围产期感染艾滋病毒(PHIV)患者的当代住院模式趋势尚不清楚。我们描述了2003年至2010年期间一大群PHIV患者按年龄组分层的住院率及原因。
纳入了通过艾滋病毒研究网络隶属于6个地理位置不同的儿科艾滋病毒中心的579名接受护理的PHIV患者。改良临床分类软件将主要国际疾病分类第九版(ICD-9)编码归入诊断类别。使用带有广义估计方程的负二项回归进行分析。
共有699次全因住院。整个队列的总体住院率为19.9/100人年,0至4岁、5至16岁和17至24岁年龄组的总体住院率分别为25.1、14.7和34.2/100人年。整个组未经调整的全因住院率呈下降趋势[每年发病率比,0.93(0.87 - 0.99)],5至16岁年龄组[0.87(0.76 - 0.99)]和17至24岁年龄组[0.87(0.80 - 0.95)]也是如此。在对CD4、HIV-1 RNA和人口统计学进行调整后,住院率不再下降。非艾滋病定义性感染和艾滋病定义性疾病共导致349次(50%)入院。这些类别的下降推动了未经调整的住院率总体下降。心血管、肾脏或任何其他诊断类别的住院率未随时间增加。
虽然住院率下降令人安心,但仍需继续努力解决PHIV患者中持续存在的高感染性和非感染性发病率问题。创新策略可能对17至24岁年龄组最为关键。心血管和肾脏入院率未增加,这为长期艾滋病毒感染和抗逆转录病毒治疗暴露导致的严重非感染性并发症提供了适度的初步安心保障。